AI Analysis | Feedback

Here are 1-2 brief analogies to describe Advanced Flower Capital (AFCG):

• A bank for the cannabis industry.

• A commercial real estate lender for cannabis companies.

AI Analysis | Feedback

• Senior Secured Loans: AFCG provides loans to cannabis companies, primarily secured by real estate, equipment, licenses, and other assets of the borrowers.
• Other Loans and Debt Securities: The company also offers various other types of loans and debt instruments to established businesses in the cannabis industry.

AI Analysis | Feedback

Advanced Flower Capital (AFCG), which operates as AFC Gamma, Inc., is a lender to established companies in the cannabis industry. Its "customers" are therefore the cannabis companies to which it provides loans and other debt financing.

Major customer companies (borrowers) of AFCG include:

• Verano Holdings Corp. (OTCQX: VRNOF, CSE: VRNO)

• Glass House Brands Inc. (OTCQX: GLASF, CSE: GLAS)

• MariMed Inc. (OTCQX: MRMD)

• TerrAscend Corp. (OTCQX: TRSSF, CSE: TSND)

AI Analysis | Feedback

AI Analysis | Feedback

Daniel Neville, Chief Executive Officer

Daniel Neville was appointed Chief Executive Officer of Advanced Flower Capital in November 2023. Prior to joining AFC Gamma, he served as Chief Financial Officer of Ascend Wellness Holdings (AWH) from August 2020 to November 2023, and before that, as SVP Finance at AWH. His earlier career included roles as a Managing Director and Analyst at SLS Capital, a special situations hedge fund, from 2010 to 2019. He also gained experience as an investment banker in Credit Suisse's Technology Group, where he focused on mergers and acquisitions (M&A) and initial public offerings (IPOs).

Brandon Hetzel, Chief Financial Officer and Treasurer

Brandon Hetzel was appointed Chief Financial Officer and Treasurer of AFC Gamma in March 2023. He joined AFC Gamma's external manager as Controller in September 2020 and was promoted to Executive Vice President, Controller in December 2022. Before his time at AFC Gamma, Mr. Hetzel served as VP of Finance for a real estate development and asset management company from August 2016 to September 2020. He also spent seven years at PricewaterhouseCoopers, progressing from Audit Associate to Audit Manager in the REIT audit practice. He possesses over twelve years of experience in real estate and financial management.

Robyn Tannenbaum, President and Chief Investment Officer

Robyn Tannenbaum serves as the President and Chief Investment Officer of Advanced Flower Capital, having been appointed Chief Investment Officer in October 2024 and President in March 2023. She has been with the company since its inception in 2020, previously holding positions such as Partner and Head of Origination, and Managing Director, Head of Originations and Investor Relations. Before joining AFC Gamma, Ms. Tannenbaum founded and served as the Managing Member of REC Investor Relations, a consulting firm specializing in strategic investor relations and financial communications, from 2017 to 2020. Her prior experience also includes being Executive Director and Head of Investor Relations at Fifth Street Asset Management (2017-2020) and a Vice President in Healthcare Investment Banking at CIT Group, Inc. (2014-2017), where she focused on mergers and acquisitions and leveraged finance transactions.

Leonard M. Tannenbaum, Chairman of the Board

Leonard M. Tannenbaum is the Chairman of the Board for Advanced Flower Capital, having transitioned from Executive Chairman and Chief Investment Officer in November 2023. He is the founder of AFC Gamma, which was incorporated in 2020. Mr. Tannenbaum is also the Founder of TCG/Tannenbaum Capital Group, an alternative investment firm focused on private credit and real estate lending. Notably, he founded Fifth Street Asset Management in 1998, a firm that grew to manage nearly $6 billion in assets across public and private investment vehicles, before its asset management business was sold to Oaktree Capital Management in 2017. His career demonstrates a consistent pattern of entrepreneurial activity and leadership in non-traditional credit markets. He also founded LMT Investments Pty Ltd. in 2017 and Sunrise Realty Trust, Inc. in 2023, and has served on the Boards of Directors of several other companies.

Gabriel Katz, Chief Legal Officer

Gabriel Katz serves as the Chief Legal Officer for Advanced Flower Capital. He brings over a decade of experience in advising both public and private companies on matters related to acquisitions, debt and equity financings, corporate governance, and continuous reporting obligations. Mr. Katz previously worked in the corporate and securities groups at national law firms and led the corporate legal team at a unicorn technology company before joining Advanced Flower Capital.

AI Analysis | Feedback

The key risks for Advanced Flower Capital (AFCG) largely stem from its specialized lending activities within the cannabis industry and its financial operational challenges.

1. Regulatory Uncertainty in the Cannabis Industry: The continued federal illegality of cannabis in the United States poses a significant and overarching risk to AFCG's business model. This regulatory landscape creates chronic barriers for its cannabis borrower clients, affecting their access to traditional banking services and potentially impacting the value and enforceability of collateral. Changes in the legal environment, or lack thereof, directly influence capital markets and the operational confidence of cannabis businesses, which in turn affects AFCG's loan portfolio and its ability to source new deals.
2. Credit Quality Deterioration and Loan Losses: AFCG has faced challenges related to the credit quality of its loans, evident in ballooning credit provisions and reported unrealized losses on certain assets. This indicates a risk of potential loan losses and non-accruals, which can significantly impact the company's profitability and asset valuation. The underperformance of legacy loans and the difficulty in recovering capital from them also contribute to this risk.
3. Liquidity Strain and Capital Market Scarcity: The company has experienced a substantial decrease in its cash reserves and has reported negative free cash flow, indicating liquidity strain. This is compounded by the limited availability of capital in the broader market for cannabis operators, making it challenging for AFCG to secure funding flexibility, manage its outstanding debt obligations, and finance new loan originations. A lack of sufficient liquidity can also put pressure on the sustainability of its dividend.

AI Analysis | Feedback

Federal cannabis legalization in the United States.

AI Analysis | Feedback

AI Analysis | Feedback

Advanced Flower Capital (AFCG) is expected to drive future revenue growth over the next 2-3 years through several key strategic initiatives and market expansions:

1. Conversion to a Business Development Company (BDC) and Expanded Investment Universe: Advanced Flower Capital successfully converted from a real estate investment trust (REIT) to a Business Development Company (BDC) in January 2026. This strategic shift significantly broadens the company's investment mandate beyond real estate-backed cannabis loans to include a wider range of secured loans and debt securities for operating businesses in the lower middle market, encompassing both cannabis and non-cannabis assets.
2. Growth of the Deal Pipeline: Following its conversion to a BDC, AFCG experienced a substantial increase in its active deal pipeline, surging from $400 million in Q3 2025 to over $1.4 billion in Q4 2025. This robust pipeline indicates a significant potential for new loan originations across its expanded investment universe, which is a key indicator for future revenue growth.
3. Redeployment of Capital from Underperforming Loans: The company is actively focused on managing and resolving underperforming loans within its portfolio. By unlocking value from these assets and receiving paydowns, AFCG plans to redeploy this capital into high-quality, cash-flowing businesses and performing credits. This strategic recycling of capital is expected to generate new interest income and enhance future earnings potential.
4. Entry into Non-Cannabis and Ancillary Cannabis Industries: As part of its expanded investment mandate as a BDC, AFCG intends to pursue direct lending opportunities in companies that are ancillary to the cannabis industry, as well as private and public middle-market companies operating outside of the cannabis sector. This diversification into new industries and markets is anticipated to broaden the company's customer base and create new sources of revenue.

AI Analysis | Feedback

Share Repurchases

• On June 15, 2023, AFC Gamma's Board of Directors authorized a share repurchase program, allowing the company to repurchase up to $20 million of its outstanding common stock.
• This share repurchase program is authorized until December 31, 2025.
• The company did not repurchase any shares of its common stock under this program during the three months ended March 31, 2024, or for the year ended December 31, 2023.

Share Issuance

• AFC Gamma completed its Initial Public Offering (IPO) in March 2021.
• On June 28, 2021, the company completed a public offering of 2,750,000 shares of its common stock.
• On January 5, 2022, AFC Gamma priced an underwritten public offering of 3,000,000 shares of common stock at $20.50 per share, anticipating gross proceeds of $61.5 million.

Outbound Investments

• AFC Gamma's primary business focuses on originating, structuring, underwriting, and investing in senior secured loans and other debt securities for established companies in the cannabis industry.
• The company has committed over $900 million in financing to the cannabis sector.
• In August 2025, the Board approved an expanded investment mandate to include direct lending opportunities in private and public middle-market companies outside the cannabis industry.

Capital Expenditures

• AFC Gamma reported $0 in Capital Expenditures for various periods, including a summary indicating 0 for cash flow from investing in some reports.
• Information regarding AFC Gamma's direct capital expenditures is generally listed as N/A in financial summaries.